BioNTech SE announced on Monday that it has begun developing a vaccine for Omicron, a concerning new coronavirus variety discovered in South Africa, however, it was unclear whether it would have to alter its existing Covid-19 vaccine.
BioNTech, which develops vaccines alongside Pfizer, said in a statement that developing an adapted vaccine is part of the company’s usual practice for new varieties, Reuters reports.
“The initial stages of designing a potential new vaccination overlap with the study required to determine whether a new shot would be required,” the report continued.
The WHO warned on Monday that the omicron variety poses a very high risk of worldwide outbreaks, as more countries reported cases, forcing border restrictions. BioNTech said on Friday that it expects further lab results in the coming two weeks to help evaluate whether an omicron-specific vaccination is needed. Moderna, a competitor, has announced that it is redesigning its Covid-19 vaccine for future booster shots.
Apart from it, you can read these articles: Samsung Galaxy S21 FE review, DaBaby net worth, Shetland Season 6, Primal Season 2, Cells at work Season 2, Goku, 6ix9ine net worth, The Shannara Chronicles Season 3, Death Note season 2, KProxy, Kung Fu Panda 4, 7StarHD, 123Mkv, Afdah, FFMovies, Bolly4U, Moviesflix, TrueID, Crystals for Protection, Mewing, How to charge crystals, Knightfall Season 3, Vampire Diaries season 9, Homeland Season 9, Sherlock season 5, Goodyear Viva 3, High sleeper bed, Cash for Cars, F95zone, the 100 Season 8, Salvation Season 3, Shadowhunters season 4, Poldark season 6, Good Place season 5, Madison beer net worth, Gravity Falls season 3, Hunter x Hunter season 7, Marvelous Mrs. Maisel Season 4, Bloodborne 2, Derry Girls season 3, and Knightfall Season 3, you can follow our Entertainment, Health, Technology, and Business category.
